CN106755082B - 高效获得大戟转基因植株的方法及其农杆菌介导转化体系 - Google Patents
高效获得大戟转基因植株的方法及其农杆菌介导转化体系 Download PDFInfo
- Publication number
- CN106755082B CN106755082B CN201611088329.3A CN201611088329A CN106755082B CN 106755082 B CN106755082 B CN 106755082B CN 201611088329 A CN201611088329 A CN 201611088329A CN 106755082 B CN106755082 B CN 106755082B
- Authority
- CN
- China
- Prior art keywords
- callus
- culture medium
- euphorbia
- agrobacterium
- culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000196324 Embryophyta Species 0.000 title claims abstract description 61
- 241000434018 Euphorbia pekinensis Species 0.000 title claims abstract description 51
- 238000000034 method Methods 0.000 title claims abstract description 31
- 230000009466 transformation Effects 0.000 title claims abstract description 27
- 230000009261 transgenic effect Effects 0.000 title claims abstract description 25
- 230000001404 mediated effect Effects 0.000 title claims abstract description 19
- 241000589158 Agrobacterium Species 0.000 title abstract description 21
- 206010020649 Hyperkeratosis Diseases 0.000 claims abstract description 85
- 230000000408 embryogenic effect Effects 0.000 claims abstract description 23
- 238000012216 screening Methods 0.000 claims abstract description 18
- 238000012258 culturing Methods 0.000 claims abstract description 13
- 230000002068 genetic effect Effects 0.000 claims abstract description 7
- 239000001963 growth medium Substances 0.000 claims description 40
- 241000221079 Euphorbia <genus> Species 0.000 claims description 29
- 230000006698 induction Effects 0.000 claims description 27
- 241000589155 Agrobacterium tumefaciens Species 0.000 claims description 24
- 230000004069 differentiation Effects 0.000 claims description 20
- 238000003752 polymerase chain reaction Methods 0.000 claims description 18
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 11
- 229930006000 Sucrose Natural products 0.000 claims description 11
- 239000005720 sucrose Substances 0.000 claims description 11
- 108090000623 proteins and genes Proteins 0.000 claims description 9
- 239000013604 expression vector Substances 0.000 claims description 8
- 108010002685 hygromycin-B kinase Proteins 0.000 claims description 8
- 210000000988 bone and bone Anatomy 0.000 claims description 7
- 230000001131 transforming effect Effects 0.000 claims description 7
- 238000005406 washing Methods 0.000 claims description 7
- 239000008223 sterile water Substances 0.000 claims description 5
- 230000001954 sterilising effect Effects 0.000 claims description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 4
- 210000000349 chromosome Anatomy 0.000 claims description 3
- 238000001962 electrophoresis Methods 0.000 claims description 3
- 210000003370 receptor cell Anatomy 0.000 claims description 3
- 238000011084 recovery Methods 0.000 claims description 3
- 238000005070 sampling Methods 0.000 claims description 3
- 229960002523 mercuric chloride Drugs 0.000 claims description 2
- LWJROJCJINYWOX-UHFFFAOYSA-L mercury dichloride Chemical compound Cl[Hg]Cl LWJROJCJINYWOX-UHFFFAOYSA-L 0.000 claims description 2
- 239000008399 tap water Substances 0.000 claims description 2
- 235000020679 tap water Nutrition 0.000 claims description 2
- 239000007788 liquid Substances 0.000 abstract description 11
- 230000001580 bacterial effect Effects 0.000 abstract description 9
- 238000003501 co-culture Methods 0.000 abstract description 3
- 208000015181 infectious disease Diseases 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract 2
- 230000003385 bacteriostatic effect Effects 0.000 abstract 1
- 229960002727 cefotaxime sodium Drugs 0.000 abstract 1
- AZZMGZXNTDTSME-JUZDKLSSSA-M cefotaxime sodium Chemical compound [Na+].N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C([O-])=O)=O)C(=O)\C(=N/OC)C1=CSC(N)=N1 AZZMGZXNTDTSME-JUZDKLSSSA-M 0.000 abstract 1
- 230000007547 defect Effects 0.000 abstract 1
- 230000001172 regenerating effect Effects 0.000 abstract 1
- 230000008929 regeneration Effects 0.000 abstract 1
- 238000011069 regeneration method Methods 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 description 7
- 238000012269 metabolic engineering Methods 0.000 description 7
- 238000011160 research Methods 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 108020004414 DNA Proteins 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 229930000044 secondary metabolite Natural products 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- 239000013612 plasmid Substances 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 206010003445 Ascites Diseases 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 238000009630 liquid culture Methods 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 150000003505 terpenes Chemical class 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- 206010016654 Fibrosis Diseases 0.000 description 2
- OJOBTAOGJIWAGB-UHFFFAOYSA-N acetosyringone Chemical compound COC1=CC(C(C)=O)=CC(OC)=C1O OJOBTAOGJIWAGB-UHFFFAOYSA-N 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 235000011148 calcium chloride Nutrition 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000007882 cirrhosis Effects 0.000 description 2
- 208000019425 cirrhosis of liver Diseases 0.000 description 2
- 239000012881 co-culture medium Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 238000009776 industrial production Methods 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 229930027917 kanamycin Natural products 0.000 description 2
- 229960000318 kanamycin Drugs 0.000 description 2
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 2
- 229930182823 kanamycin A Natural products 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 2
- 229960001225 rifampicin Drugs 0.000 description 2
- 201000000980 schizophrenia Diseases 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 1
- 101100184662 Caenorhabditis elegans mogs-1 gene Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000221017 Euphorbiaceae Species 0.000 description 1
- 206010017753 Gastric atony Diseases 0.000 description 1
- 241000521257 Hydrops Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 208000008423 pleurisy Diseases 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 201000004409 schistosomiasis Diseases 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
- C12N15/8202—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by biological means, e.g. cell mediated or natural vector
- C12N15/8205—Agrobacterium mediated transformation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611088329.3A CN106755082B (zh) | 2016-11-30 | 2016-11-30 | 高效获得大戟转基因植株的方法及其农杆菌介导转化体系 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611088329.3A CN106755082B (zh) | 2016-11-30 | 2016-11-30 | 高效获得大戟转基因植株的方法及其农杆菌介导转化体系 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106755082A CN106755082A (zh) | 2017-05-31 |
CN106755082B true CN106755082B (zh) | 2020-03-27 |
Family
ID=58915274
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611088329.3A Active CN106755082B (zh) | 2016-11-30 | 2016-11-30 | 高效获得大戟转基因植株的方法及其农杆菌介导转化体系 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106755082B (zh) |
-
2016
- 2016-11-30 CN CN201611088329.3A patent/CN106755082B/zh active Active
Non-Patent Citations (2)
Title |
---|
优良年宵花一品红组培快繁技术;王伯诚等;《上海农业科技》;20071231(第1期);70-71 * |
六种矮型一品红的离体组织培养研究;蒋小满等;《北方园艺》;20021231(第3期);62-63 * |
Also Published As
Publication number | Publication date |
---|---|
CN106755082A (zh) | 2017-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107974455A (zh) | 橡胶树白粉菌内源启动子wy7及其用途 | |
CN110172476B (zh) | 一种马缨杜鹃的遗传转化和再生体系建立的方法 | |
CN107475287B (zh) | 一种茄子遗传转化方法 | |
CN111635904B (zh) | 一种增强黄瓜靶斑病抗性的基因CsWRKY10及其应用 | |
CN108396035A (zh) | 一种农杆菌介导水稻遗传转化方法 | |
CN106755082B (zh) | 高效获得大戟转基因植株的方法及其农杆菌介导转化体系 | |
CN109536513B (zh) | 白菜雌蕊发育相关基因BrCRF11a及其应用 | |
CN102399795A (zh) | 利用颠茄托品酮还原酶i型基因提高颠茄莨菪烷类生物碱含量的方法 | |
CN105907733A (zh) | 一种苦豆子肌醇甲基转移酶及其编码基因及应用 | |
CN110106171A (zh) | 长链非编码rna及其在调控植物耐低温中的应用 | |
CN109371060B (zh) | 一种桃叶卫矛快速转基因的方法 | |
CN109536514B (zh) | 白菜雌蕊发育相关基因BrCRF6及其应用 | |
CN105861543A (zh) | 一种建立农杆菌介导豆瓣绿高效转染体系的方法 | |
CN108841853B (zh) | 一种以草甘膦为筛选剂的胡萝卜遗传转化的方法 | |
CN106119276A (zh) | 一种建立农杆菌介导灯盏花高效转染体系的方法 | |
CN110699377A (zh) | 一种花生转基因的方法 | |
CN105886527A (zh) | 一种高效获得海滨雀稗转基因植株的农杆菌介导转化体系及其应用 | |
CN110951776A (zh) | 一种农杆菌介导的辣椒遗传转化方法 | |
CN110106172A (zh) | 一种长链非编码rna及其在调控植物耐低温中的应用 | |
CN105018493B (zh) | 水稻OsAHL1基因的启动子及包含其的重组载体、转化体以及其应用 | |
CN108277233A (zh) | 水稻成熟胚愈伤组织的诱导培养方法 | |
CN114958904B (zh) | 一种快速获得萝卜转基因材料的方法 | |
CN116837024B (zh) | 一种利用农杆菌瞬时转化菰米种子进行基因表达的方法 | |
KR101174491B1 (ko) | 아그로박테리움을 이용한 배추의 형질전환 효율을 증가시키는 방법 | |
CN111937749B (zh) | 钩藤发根的高效诱导和培养方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20221013 Address after: No.0609-2, Floor 6, Building 1, Business Center, Nanning Comprehensive Bonded Zone, No. 20, Jinhai Road, Nanning District, Nanning (Guangxi) Pilot Free Trade Zone, 530000 Guangxi Zhuang Autonomous Region Patentee after: Guangxi Wulitong Biotechnology Co.,Ltd. Address before: 221011 No. 2 Yucai Road, Jiawang District, Jiangsu, Xuzhou Patentee before: Jiangsu Normal University |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231225 Address after: No.0609-2, Floor 6, Building 1, Business Center, Nanning Comprehensive Bonded Zone, No. 20, Jinhai Road, Nanning District, Nanning (Guangxi) Pilot Free Trade Zone, 530000 Guangxi Zhuang Autonomous Region Patentee after: Guangxi Huahong Medicinal Food Plant Biotechnology Industry Research Institute Co.,Ltd. Address before: No.0609-2, Floor 6, Building 1, Business Center, Nanning Comprehensive Bonded Zone, No. 20, Jinhai Road, Nanning District, Nanning (Guangxi) Pilot Free Trade Zone, 530000 Guangxi Zhuang Autonomous Region Patentee before: Guangxi Wulitong Biotechnology Co.,Ltd. |